Literature DB >> 18181944

Source of cell injected is a critical factors for short and long engraftment in xeno-transplantation.

G Noia1, M S Ligato, E Cesari, D Visconti, G Fortunato, M Tintoni, I Mappa, C Greco, M E Caristo, G Bonanno, M Corallo, L Minafra, A Perillo, M Terzano, S Rutella, G Leone, G Scambia, M Michejda, S Mancuso.   

Abstract

This study aims to investigate engraftment of human cord blood and foetal bone marrow stem cells after in utero transplantation via the intracoelomic route in the sheep. Here, we performed transplantation in 14 single and 1 twin sheep foetuses at 40-47 days of development, using a novel schedule for injection. (i) Single injection of CD34(+) human cord blood stem cells via the coelomic route (from 10 to 50 x 10(4)) in seven single foetuses. (ii) Single injection of CD34(+) foetal bone marrow stem cells via the intracoelomic route with further numbers of cells (20 x 10(5) and 8 x 10(5), respectively) in three single and in one twin foetuses. (iii) Double fractioned injection (20-30 x 10(6)) via the coelomic route and 20 x 10(6) postnatally, intravenously, shortly after birth of CD3-depleted cord blood stem cells in four single foetuses. In the first group, three single foetuses showed human/sheep chimaerism at 1, 8 and 14 months after birth. In the second group, the twin foetuses showed human/sheep chimaerism at 1 month after birth. In the third group, only two out of four single foetuses that underwent transplantation showed chimaerism at 1 month. While foetal bone marrow stem cells showed good short-term engraftment (1 month after birth), cord blood stem cells were able to persist longer in the ovine recipients (at 1, 8 and 14 months after birth).

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18181944      PMCID: PMC6496627          DOI: 10.1111/j.1365-2184.2008.00481.x

Source DB:  PubMed          Journal:  Cell Prolif        ISSN: 0960-7722            Impact factor:   6.831


  21 in total

1.  Postnatal booster injections increase engraftment after in utero stem cell transplantation.

Authors:  R Milner; A Shaaban; H B Kim; C Fichter; A W Flake
Journal:  J Surg Res       Date:  1999-05-01       Impact factor: 2.192

Review 2.  Fetal stem cells.

Authors:  Keelin O'Donoghue; Nicholas M Fisk
Journal:  Best Pract Res Clin Obstet Gynaecol       Date:  2004-12       Impact factor: 5.237

Review 3.  Stem cells in the umbilical cord.

Authors:  Mark L Weiss; Deryl L Troyer
Journal:  Stem Cell Rev       Date:  2006       Impact factor: 5.739

4.  Cotransplantation of human stromal cell progenitors into preimmune fetal sheep results in early appearance of human donor cells in circulation and boosts cell levels in bone marrow at later time points after transplantation.

Authors:  G Almeida-Porada; C D Porada; N Tran; E D Zanjani
Journal:  Blood       Date:  2000-06-01       Impact factor: 22.113

5.  Free amino acid distribution inside the first trimester human gestational sac.

Authors:  E Jauniaux; B Gulbis; E Gerlo; C Rodeck
Journal:  Early Hum Dev       Date:  1998-05-29       Impact factor: 2.079

Review 6.  [Umbilical cord blood as a source of stem cells].

Authors:  Ines Bojanić; Branka Golubić Cepulić
Journal:  Acta Med Croatica       Date:  2006-06

7.  Purification of primitive human hematopoietic cells capable of repopulating immune-deficient mice.

Authors:  M Bhatia; J C Wang; U Kapp; D Bonnet; J E Dick
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-13       Impact factor: 11.205

8.  Engraftment and long-term expression of human fetal hemopoietic stem cells in sheep following transplantation in utero.

Authors:  E D Zanjani; M G Pallavicini; J L Ascensao; A W Flake; R G Langlois; M Reitsma; F R MacKintosh; D Stutes; M R Harrison; M Tavassoli
Journal:  J Clin Invest       Date:  1992-04       Impact factor: 14.808

9.  The intracoelomic route: a new approach for in utero human cord blood stem cell transplantation.

Authors:  Giuseppe Noia; Luca Pierelli; Giuseppina Bonanno; Giovanni Monego; Alessandro Perillo; Sergio Rutella; Anna Franca Cavaliere; Gianluca Straface; Giuseppe Fortunato; Elena Cesari; Giovanni Scambia; Marinella Terzano; Enrico Iannace; Giovanni Zelano; Fabrizio Michetti; Giuseppe Leone; Salvatore Mancuso
Journal:  Fetal Diagn Ther       Date:  2004 Jan-Feb       Impact factor: 2.587

Review 10.  Which stem cells should be used for transplantation?

Authors:  Maria Michejda
Journal:  Fetal Diagn Ther       Date:  2004 Jan-Feb       Impact factor: 2.587

View more
  4 in total

1.  Development and characterization of a novel CD34 monoclonal antibody that identifies sheep hematopoietic stem/progenitor cells.

Authors:  Christopher D Porada; Duygu D Harrison-Findik; Chad Sanada; Vincent Valiente; David Thain; Paul J Simmons; Graça Almeida-Porada; Esmail D Zanjani
Journal:  Exp Hematol       Date:  2008-12       Impact factor: 3.084

2.  Long-term follow-up study on the engraftment of human hematopoietic stem cells in sheep.

Authors:  Tomoyuki Abe; Yutaka Hanazono; Yoshikazu Nagao
Journal:  Exp Anim       Date:  2014-07-22

3.  Assessment of Short-Term Engraftment Potential of Ex Vivo Expanded Hematopoietic Stem Cells Using Normal Fetal Mouse in Utero Transplantation Model.

Authors:  Morteza Zarrabi; Elaheh Afzal; Mohammad Hassan Asghari; Marzieh Ebrahimi
Journal:  Cell J       Date:  2019-06-15       Impact factor: 2.479

Review 4.  Experimental and clinical progress of in utero hematopoietic cell transplantation therapy for congenital disorders.

Authors:  Chunyu Shi; Lu Pan; Zheng Hu
Journal:  Front Pharmacol       Date:  2022-09-02       Impact factor: 5.988

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.